Stroke News

Toxic metals such as lead, cadmium and arsenic found in food and water represent a significant hazard CV health in the U.S., particularly among historically underrepresented communities, according to a scientific statement.

WASHINGTON — Patients who experienced a COPD exacerbation had a greater risk for acute cardiovascular events than patients who did not, according to a presentation at the American Thoracic Society International Conference.

PHILADELPHIA — Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation are safe in most high-risk populations, a speaker said during the Heart in Diabetes CME Conference.

AstraZeneca announced the ANNEXA phase IV trial assessing the safety and efficacy of andexanet alfa stopped early after achieving prespecified criteria on hemostatic efficacy vs. usual care, according to a press release.

The incidence of stroke, thrombocytopenia and thrombosis were rare in patients following COVID-19 vaccination, while all three complications were more likely in patients who received an influenza vaccination, a report found.

Healio and Cardiology Today have compiled the top cardiology headlines of May 2023.

Modeling data suggest that patterns of temperature, air pressure, precipitation and air pollution assessed over a decade are associated with hospitalizations related to HF, MI and ischemic stroke, researchers reported.

SGLT2 inhibition was associated with reduced 5-year risk for stroke among patients with concomitant atrial fibrillation and diabetes, according to a study in the Journal of the American Heart Association.

Approximately one in four stroke survivors will experience a second stroke within 5 years, according to data from the American Stroke Association, yet research shows many patients still do not receive adequate follow-up and support.

Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals announced all three prospective antithrombotic indications for milvexian have received fast track designation from the FDA.